Jaguar Health, Inc. (JAGX)
0.319
-0.05
(-12.91%)
USD |
NASDAQ |
Sep 10, 16:00
0.3237
0.00 (0.00%)
After-Hours: 20:00
Jaguar Health Enterprise Value : 11.80M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 11.80M |
| September 08, 2026 | 12.03M |
| September 04, 2026 | 12.92M |
| September 03, 2026 | 13.39M |
| September 02, 2026 | 13.57M |
| September 01, 2026 | 13.57M |
| August 31, 2026 | 13.86M |
| August 28, 2026 | 13.95M |
| August 27, 2026 | 14.22M |
| August 26, 2026 | 14.49M |
| August 25, 2026 | 14.51M |
| August 24, 2026 | 14.45M |
| August 21, 2026 | 14.23M |
| August 20, 2026 | 14.26M |
| August 19, 2026 | 14.51M |
| August 18, 2026 | 14.76M |
| August 17, 2026 | 14.29M |
| August 14, 2026 | 14.47M |
| August 13, 2026 | 13.82M |
| August 12, 2026 | 13.71M |
| August 11, 2026 | 13.83M |
| August 10, 2026 | 14.07M |
| August 07, 2026 | 14.63M |
| August 06, 2026 | 14.58M |
| August 05, 2026 | 15.14M |
| Date | Value |
|---|---|
| August 04, 2026 | 14.88M |
| August 03, 2026 | 14.88M |
| July 31, 2026 | 14.88M |
| July 30, 2026 | 15.07M |
| July 29, 2026 | 14.71M |
| July 28, 2026 | 14.70M |
| July 27, 2026 | 14.88M |
| July 24, 2026 | 14.70M |
| July 23, 2026 | 15.02M |
| July 22, 2026 | 16.48M |
| July 21, 2026 | 16.14M |
| July 20, 2026 | 16.16M |
| July 17, 2026 | 16.33M |
| July 16, 2026 | 16.50M |
| July 15, 2026 | 19.49M |
| July 14, 2026 | 20.56M |
| July 13, 2026 | 20.95M |
| July 10, 2026 | 21.24M |
| July 09, 2026 | 21.53M |
| July 08, 2026 | 21.73M |
| July 07, 2026 | 22.94M |
| July 06, 2026 | 23.67M |
| July 02, 2026 | 23.67M |
| July 01, 2026 | 24.79M |
| June 30, 2026 | 24.59M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Reviva Pharmaceuticals Holdings, Inc. | -12.77M |
| Jupiter Neurosciences, Inc. | 2.308M |
| ANI Pharmaceuticals, Inc. | 1.859B |
| Corcept Therapeutics, Inc. | 12.19B |
| Veru, Inc. | 19.18M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.80M |
| Revenue (Quarterly) | 1.225M |
| Total Expenses (Quarterly) | 13.91M |
| EPS Diluted (Quarterly) | -15.70 |
| Gross Profit Margin (Quarterly) | -22.04% |
| Profit Margin (Quarterly) | -1.05K% |
| Earnings Yield | -114.6K% |
| Normalized Earnings Yield | -98408.71 |